Effect of quinine therapy on plasma glucose and plasma insulin levels in pregnant women infected with Plasmodium falciparum malaria in Gezira state
AbstractTo determine if quinine has a metabolic effect during treatment of severe or complicated malaria, we studied its effects on plasma glucose and plasma insulin levels in 150 pregnant women with malaria referred to Madani maternity teaching hospital, Gezira state and 50 healthy pregnant controls. Levels were determined at baseline [day 0] before the start of quinine treatment, after 2 days of treatment [2 hours after the 4th dose] and after 7 days of treatment [day 8]. There was a statistically significant increase in plasma insulin concentrations during the quinine infusion and fall in plasma glucose concentration [P<0.001]. Quinine administered at the recommended dose and rate can disrupt plasma glucose homeostasis although it is still the drug of choice for severe and complicated malaria in Sudan
Elbadawi, N.E.E., Mohamed, M.I., Dawod, O.Y., Ali, K.E., Daoud, O.H. et al. (2011). Effect of quinine therapy on plasma glucose and plasma insulin levels in pregnant women infected with Plasmodium falciparum malaria in Gezira state. http://www.who.int/iris/handle/10665/118142
EMHJ - Eastern Mediterranean Health Journal, 17 (9), 697-700, 2011
MetadataShow full item record
Showing items related by title and MeSH subject.
Frequency of impaired glucose tolerance and diabetes mellitus in subjects with fasting blood glucose below 6.1 mmol/L [110 mg/dL] Khan, S.H.; Ijaz, A.; Bokhari, S.A. Raza; Hanif, M.S.; Azam, N. (2013)The diagnosis of diabetes mellitus by the available criteria is controversial and relies heavily on fasting glucose results. This cross-sectional study in 2010-2011 aimed to measure the frequency of impaired glucose tolerance and diabetes mellitus in 127 subjects having fasting blood glucose < 7.0 mmol/L and to measure the agreement between different standard diagnostic criteria. Subjects presenting to a laboratory for analysis of fasting blood glucose for excluding diabetes meilitus underwent a 2-hour 75 g oral glucose challenge. A total of 40.6% ...
Message from, Dr Hussein A. Gezairy, Regional Director, WHO Eastern Mediterranean Region, to the regional consultation for quality assurance, and safety of plasma and plasma derivatives, Cairo, Egypt, 31 January-3 February 2005 World Health Organization, Regional Office for the Eastern Mediterranean (2005)
WHO Global Programme on AIDS; League of Red Cross Societies; Global Blood Safety Initiative; World Health Organization. Health Laboratory Technology Unit (WHO/GPA/INF/89.17WHO/LAB/89.9. Unpublished, 1989)